Suven Life Sciences Limited (NSE:SUVEN)

Suven Life Sciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	70,150	35,035	24,730	21,742	10,570	13,484
Market Cap Growth	145.46%	41.67%	13.74%	105.69%	-21.61%	50.48%
Enterprise Value	65,136	32,460	23,067	19,870	10,468	13,313
Last Close Price	265.45	131.70	113.67	100.00	48.50	85.42
PS Ratio	333.33	166.48	371.55	185.94	77.75	112.83
PB Ratio	11.86	5.92	22.48	8.05	2.82	14.03
P/TBV Ratio	11.86	5.93	22.52	8.06	2.82	14.06
EV/Sales Ratio	-	154.24	346.57	169.93	77.00	111.40
Debt / Equity Ratio	0.03	0.03	-	0.00	0.00	0.03
Net Debt / Equity Ratio	-0.85	-0.85	-0.55	-0.89	-0.60	-0.49
Net Debt / EBITDA Ratio	1.85	1.85	0.36	1.86	1.80	0.39
Net Debt / FCF Ratio	1.63	1.63	0.31	2.07	1.91	0.32
Asset Turnover	0.06	0.06	0.03	0.04	0.06	0.10
Inventory Turnover	-	-	1.59	2.30	27.66	9.10
Quick Ratio	16.94	16.94	2.62	18.01	21.03	7.13
Current Ratio	17.70	17.70	3.21	18.99	22.61	8.01
Return on Equity (ROE)	-78.80%	-78.80%	-84.60%	-32.56%	-50.17%	-119.51%
Return on Assets (ROA)	-45.46%	-45.46%	-50.94%	-24.91%	-33.21%	-66.72%
Return on Invested Capital (ROIC)	-423.42%	-352.59%	-423.40%	-149.73%	-133.77%	-218.87%
Return on Capital Employed (ROCE)	-46.50%	-46.50%	-153.30%	-49.50%	-35.00%	-126.60%
Earnings Yield	-3.94%	-7.89%	-6.50%	-4.83%	-11.19%	-9.05%
FCF Yield	-4.37%	-8.76%	-7.74%	-5.31%	-11.25%	-10.93%
Dividend Yield	-	-	-	-	-	1.17%
Buyback Yield / Dilution	-4.47%	-4.47%	-	-22.31%	-32.29%	-5.88%
Total Shareholder Return	-4.47%	-4.47%	-	-22.31%	-32.29%	-4.71%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.